The immune response to influenza virus infection comprises both innate and adaptive defenses. NK cells play an early role in the destruction of tumors and virally-infected cells. NK cells express a variety of inhibitory receptors, including those of the Ly49 family, which are functional homologs of human killer-cell immunoglobulin-like receptors (KIR). Like human KIR, Ly49 receptors inhibit NK cell-mediated lysis by binding to major histocompatibility complex class I (MHC-I) molecules that are expressed on normal cells. During NK cell maturation, the interaction of NK cell inhibitory Ly49 receptors with their MHC-I ligands results in two types of NK cells: licensed ("functional"), or unlicensed ("hypofunctional"). Despite being completely dysfunctional with regard to rejecting MHC-I-deficient cells, unlicensed NK cells represent up to half of the mature NK cell pool in rodents and humans, suggesting an alternative role for these cells in host defense. Here, we demonstrate that after influenza infection, MHC-I expression on lung epithelial cells is upregulated, and mice bearing unlicensed NK cells (Ly49-deficient NKC KD and MHC-I-deficient B2m -/-mice) survive the infection better than WT mice. Importantly, transgenic expression of an inhibitory self-MHC-I-specific Ly49 receptor in NKC KD mice restores WT influenza susceptibility, confirming a direct role for Ly49. Conversely, F(ab') 2 -mediated blockade of self-MHC-I-specific Ly49 inhibitory receptors protects WT mice from influenza virus infection. Mechanistically, perforin-deficient NKC KD mice succumb to influenza infection rapidly, indicating that direct cytotoxicity is necessary for unlicensed NK cell-mediated protection. Our findings demonstrate that Ly49:MHC-I interactions play a critical role in influenza virus pathogenesis. We suggest a similar role may be conserved in human KIR, and their blockade may be protective in humans. 
Introduction
Influenza viruses are classified as members of the Orthomyxoviridae family, which are enveloped viruses with a segmented, negative, single-stranded RNA (ssRNA) genome that contains 7-8 gene segments. Structurally, influenza A virus expresses two surface glycoproteins, hemagglutinin and neuraminidase [1, 2] . Influenza A virus can cause severe human illness, including upper and lower respiratory tract infections and pneumonia, and is associated with major human pandemics. Seasonal influenza epidemics result in 250,000-500,000 deaths worldwide annually [3] .
NK cells are innate lymphocytes that play a critical role in host defense against tumors and virus infection, both by directly eliminating them and by enhancing the rapid development of adaptive responses [4] [5] [6] . NK cells are important for protection against influenza virus infection in various animal models [5, 7, 8] . In response to NK cell cytolytic function, influenza virus has developed several evasion strategies to escape NK cell recognition [9, 10] . Importantly, influenza virus infection was shown to induce accumulation of MHC-I molecules in the lipid raft microdomains of infected cells, leading to increased binding of the NK cell inhibitory receptor KIR2DL1 and inhibition of human NK cell cytotoxicity in vitro [11, 12] .
NK cell effector functions are tightly controlled by the combination of signals received through germline-encoded activating and inhibitory receptors [6, 13] . Mouse NK receptors include the Ly49, NKG2, and NKR-P1 families of receptors encoded in the Natural Killer gene Complex (NKC) on chromosome 6 [13, 14] . Inhibitory receptors engage molecular indicators of health, while activating receptors engage indicators of disease. By integrating these signals, the NK cell can appropriately spare or destroy a potential target [14] . Ly49 family members are type II transmembrane glycoproteins, part of the C-type lectin superfamily that forms disulphide-linked homodimers [15] . The mouse Ly49 are functionally equivalent to human killercell immunoglobulin-like receptors (KIR). The ligands for KIR and Ly49 receptors are self MHC-I molecules or MHC-I related molecules that are expressed by pathogens upon infection [5, 16, 17] .
Beyond regulating NK cell killing, interactions between MHC-I and Ly49 receptors are required for NK cell education. The licensing hypothesis states that, to be fully functional, a developing NK cell must successfully engage a self-ligand with an inhibitory receptor [18, 19] . In a C57BL/6 mouse, this is canonically achieved by engagement of MHC-I by Ly49C and/or Ly49I. Accordingly, NK cells that do not express Ly49C/I, or cells from MHC-I-deficient or Ly49-deficient (NKC KD ) mice, are 'unlicensed', displaying attenuated responses to MHC-Ideficient tumors in vitro and in vivo [19] [20] [21] [22] . NKC KD mice also develop lymphomas earlier than WT mice, again suggesting a degree of dysfunction in unlicensed NK cells [22] . Despite being unlicensed, however, these Ly49C/I -cells represent up to half of the population of mature NK cells in a healthy, WT mouse [9, 18, [23] [24] [25] , suggesting a role for these cells in host defense. Since these unlicensed cells are dysfunctional with regard to rejecting MHC-I-deficient tumors, their role in host defense may be in NK-mediated anti-pathogen activity. MHC-I-deficient (B2m -/-) mice, which bear only unlicensed NK cells, exhibit robust NK cell responses and can control mouse cytomegalovirus (MCMV) infection as efficiently as WT mice [26, 27] . A publication by Orr et al. found that adoptively transferred unlicensed Ly49C/I -Ly49G2 + NK cells into MCMV-infected neonates enhanced their survival better than the licensed, Ly49C/I + Ly49G2 + cells [28] . For a more in-depth analysis of the role of unlicensed NK cells in viral infection, we have used Ly49-deficient (NKC KD ) mice generated in our laboratory [20] 
Materials and Methods

Mice
C57BL/6 (B6) and B6.129P2-B2m tm1 Unc/J (B2m -/-) mice were purchased from The Jackson Laboratory (Bar Harbor, ME), Ifnar1 -/-were obtained from Dr. Subash Sad (University of strain influenza virus [30] . Influenza-infected mice were housed in a level 2 confinement area for the duration of the experiment. Body weight was measured daily. Animals were considered to be at endpoint if weight loss exceeded 25% of the body weight prior to infection, or if the animal was moribund. Viral loads of infected mice were determined by plaque assay, as described previously [30] . Virus titer is expressed as the number of plaque forming units per gram of lung (PFU/g).
In vivo mAb treatments
Anti-NK1.1 mAb (clone PK136), anti-IFN-γ mAb (clone XMG1.2), and anti-Ly49C/I F(ab') 2 mAb (clone 5E6) were injected i.p. into groups of age and sex-matched WT mice. 200 μg of mAb per mouse were injected i.p. two days prior to influenza virus infection, on the day of infection, and every two days post-infection until day 10 p.i. Anti-AsialoGM1 antibody (Wako Pure Chemical Industries, Osaka, Japan) was injected i.p. two days prior to influenza virus infection (25 μl), on the day of infection (25 μl), and every three days post-infection (10 μl) until day 10 p.i.
Lung epithelial cell isolation and staining
Lungs were removed and minced in 5 ml RPMI with 0.5 mg/ml collagenase D (Roche), followed by incubation for 1 h at 37°C with agitation. The minced pieces were crushed on a 70 μm cell strainer to prepare single cell suspensions for flow cytometry as previously described.
Antibodies and flow cytometry
Anti-mouse CD18 (LFA-1), CD326 (EpCAM), MHC-I (H-2K b ), 5E6 (anti-Ly49C/I), 4D11 (anti-Ly49G), CD8 (CD8β), CD4, CD3, TCRβ, NKp46 (CD335), NKG2D (CD314), NKG2A (16a11), NKG2A/C/E (20d5), CD27, CD11b, CD107a (1D4B), IFN-γ (XMG1.2), and Live/ Dead stain were purchased from eBioscience (eBioscience, San Diego, CA, USA). Anti-NKG2D (CD314) was purchased from BioLegend (BioLegend, San Diego, CA, USA). Antimouse TCRβ chain was purchased from BD Biosciences (BD Biosciences, Mississauga, Ontario, Canada). PK136 (anti-NK1.1), 5E6 (anti-Ly49C/I B6 ), and XMG1.2 (anti-IFN-γ) hybridomas were kind gifts from Drs. James Carlyle (Sunnybrook Research Institute, Toronto, ON), Charles Sentman (Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire), and Subash Sad (University of Ottawa, Ottawa, ON), respectively. Cell fluorescence data was acquired with a CyAN-ADP flow cytometer (Beckman Coulter) and analyzed with Kaluza software (Beckman Coulter, New Jersey, USA).
The levels of cytokines and chemokines in lung tissue homogenates were measured by bead array flow cytometry using the mouse Th1/Th2/Th17/Th22-13plex FlowCytomix multiplex kit and mouse chemokine 6plex kit (eBioscience, San Diego, CA, USA).
Tetramer staining
Streptavidin-PE conjugated influenza A non-structural protein (NS2) 114 
In vitro NK cell assay
Total lymphocytes isolated from the lungs were incubated with YAC-1 cells at 1:1 ratio or with phorbol 12-myristate 13-acetate (PMA, 10 μg/ml) and ionomycin (1 μg/ml) in the presence of anti-CD107a mAb and brefeldin A (eBiosience) for 4 h. Cells were stained for surface markers followed by intracellular staining for IFN-γ using IC fixation and permeabilization reagents (eBioscience) following manufacturer's instructions.
Purification and modification of mAbs
Individual hybridoma clones were cultured in DMEM supplemented with 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 0.1 mM β-mercaptoethanol, 100 U/ml penicillin, and 100 μg/ml streptomycin. Culture supernatants were then centrifuged (10,000x g for 20 min) and filtered through a 0.45 μm filter. Monoclonal antibodies (mAb) were purified using Protein G sepharose chromatography (ExalphaBiologicals, Inc, USA). Monoclonal Ab was dialyzed against 1x PBS buffer (pH 7.4) and then concentrated using an Amicon ultra-15 centrifugal filter unit with an ultracel-100 kDa membrane (EMD Millipore Corporation, MA, USA). Monoclonal Ab concentration was determined by SDS-PAGE gel and by spectrophotometric measurement at 280 nm. To make 5E6 F(ab') 2 fragments [31] , mAb was dialyzed twice against 100 mM sodium acetate solution (pH 4.0), digested using pepsin (Sigma-Aldrich, Ontario, Canada), and then dissolved in 100 mM sodium acetate solution (pH 4.0) at a 1:40 pepsin to mAb ratio for 10 h at 37°C. The digested mAb was dialyzed against 1x PBS buffer (pH 7.4) and then concentrated using an Amicon ultra-15 centrifugal filter unit with an ultracel-50 kDa membrane (EMD Millipore Corporation, MA, USA). F(ab') 2 fragments were then purified using protein A affinity chromatography. 5E6 F(ab') 2 fragment concentration was determined by SDS-PAGE gel and by spectrophotometric measurement at 280 nm. The purity of 5E6 F(ab') 2 fragments was determined by SDS-PAGE gel.
Lung histopathology
Lungs were collected from infected mice 7 days p.i. and fixed in 10% neutral buffered formalin (25 ml) for 24 h. Subsequently, lungs were embedded in paraffin, sectioned at a thickness of 4 μm and stained with hematoxylin and eosin (H&E). Slides were examined under a microscope to score histopathologic changes in the lungs by a pathologist blind to the experimental conditions.
Statistical analysis
Statistical comparisons were made by a two-tailed Student's t-test, one-way ANOVA with Bonferroni post-hoc test, or Kaplan Meier survival statistical analysis (log rank test) using GraphPad Prism software (GraphPad, San Diego, USA). A p value <0.05 was considered statistically significant.
Results
Ly49-deficient mice are protected from lethal influenza virus infection
It is well established that influenza virus infection in vitro inhibits NK cell cytotoxicity by enhancing NK cell inhibitory receptor binding to MHC-I on infected human lung epithelial cells [11, 12] . It is possible that MHC-I has direct negative effects on NK cell activity during influenza virus infection in mice as well. To test this, we first determined whether influenza virus infection could modulate MHC-I expression on mouse lung epithelial cells. WT (B6) mice were infected with 600 PFU of mouse-adapted influenza strain A/FM/1/47 (H1N1) (FM-MA) intranasally. MHC-I expression was determined on EpCAM + (CD326) lung epithelial cells on day 5 post-infection (p.i.) by flow cytometry. In uninfected mice, low levels of MHC-I expression were detected on lung epithelial cells (Fig 1A) . However, upon infection with influenza virus, lung epithelial cell expression of MHC-I was dramatically increased ( Fig  1A) . As a control, infected and uninfected MHC-I-deficient mice (B2m -/-mice) were included, and as expected, displayed no increase in MHC-I staining upon infection. Influenza virus infection is known to upregulate type I IFN (IFN-I) production, which in turn drives the upregulation of a variety of immunomodulatory proteins including MHC-I. To determine whether this upregulation is mediated by IFN-I production, we infected WT (B6) and mice deficient in the receptor for IFN-α and IFN-β (Ifnar1 -/-) with 600 PFU FM-MA virus intranasally. Lungs were harvested on day 5 p.i. Interestingly, expression levels of MHC-I were similar between WT (B6) and Ifnar1 -/-mice (Fig 1B) , confirming this upregulation was independent of IFN-I.
These data demonstrate that influenza virus infection induces upregulation of MHC-I expression on lung epithelial cells. Increased expression of MHC-I on lung epithelial cells upon influenza virus infection may have implications for the inhibition of NK cells through interaction with inhibitory Ly49 receptors.
Recently, we reported that Ly49-deficient (NKC KD ) mice exhibit uncontrolled tumor growth and metastases [22] . Lacking licensed NK cells renders these mice highly susceptible to tumor formation, despite having otherwise normal mature NK cells. Flow cytometry analysis of lung lymphocytes showed that NK cells in the lungs of NKC KD mice were mostly devoid of Ly49 expression (Fig 1C) , but were otherwise predominantly mature cells (CD11b + CD27 low )
with normal expression of the activating receptors NKp46 and NKG2D (Fig 1C and 1D ). To determine whether Ly49 interaction with MHC-I molecules is relevant to influenza infection in vivo, we inoculated WT and NKC KD mice with 1050 PFU of FM-MA intranasally. The animals were observed daily for over two weeks, and sacrificed when moribund. Death due to infection began occurring on day 8 p.i. (Fig 1E) . Two weeks p.i., almost 90% of the WT mice had succumbed to the infection, while unexpectedly, only 35% of the NKC KD mice succumbed (Fig 1E, ÃÃ p = 0.0072). Next, we depleted NK cells in our mouse model to confirm the role of NK cells during influenza virus infection. This depletion was performed with anti-AsialoGM1 treatment instead of the standard NK1.1 treatment, as these mice express an allele of NKR-P1C that is not recognized by the NK1.1 antibody. Anti-AsialoGM1 is known to deplete some activated macrophages and CD8 + T cells at high doses [32, 33] . We used a dose that showed total NK depletion without T cell depletion (S1A Fig); however, depletion of activated T cells and activated macrophages remains a possibility. Depletion of NK cells from NKC KD mice using antiAsialoGM1 treatment (S1B Fig) resulted in a complete loss of protection (Fig 1F) , indicating that NK cells from NKC KD mice play a key role in protecting those mice from influenza. Very low (50 PFU) or high (5000 PFU) doses were too extreme to note any survival differences, but 600 PFU gave similar results to 1050 PFU (S2A Fig, Fig 1E and 1F) , therefore, 600 PFU infection dose was used for the remainder of the study. NKC KD mice lack Ly49Q, which plays an important role in IFN-α production by plasmacytoid dendritic cells [29, 34] . To confirm that this survival advantage is not due to a loss of Ly49Q alone, we inoculated Ly49Q KO mice with influenza virus. Like WT mice, Ly49Q KO mice died 10 days post influenza virus infection ( Fig 1E, ÃÃ p = 0.0049). NKC KD mice also express lower levels of NKG2A/C/E. However, the inhibitory NKG2A is not believed to be involved in influenza protection by NK cells [35] , and its expression is not altered in B2m dominates the lung microenvironment in the steady-state (Fig 2A, left) , following infection, the unlicensed Ly49C/I -G + population shows more dramatic expansion (Fig 2A, right) . This can be attributed in part to the greater number of proliferating cells in this subpopulation following infection (Fig 2B) . NK cells were activated (IFN-γ + and CD107a + ) upon infection with influenza virus, however, we observed equal levels of intracellular IFN-γ levels in all of these four NK cell subsets (S4 and S5 Figs). While we see an outgrowth of the Ly49G + cells in the WT mice following infection, we observe no similar outgrowth from the residual Ly49G + cells present in NKC KD mice (Fig 2C) , indicating that it is likely a lack of Ly49C/I, and not the presence of Ly49G, that is conferring the survival advantage in these animals. (Fig 2D and 2E) . Therefore, the presence of a larger number of activated NK cells, which are not inhibited via interaction with the increased expression of MHC-I molecules on the lung epithelial cells in the influenza-infected mice (Fig 1A) , may confer a survival advantage to NKC KD compared to the WT mice, during an influenza virus infection.
WT mice exhibit higher lung viral loads in comparison to NKC KD , resulting in severe lung immunopathology, following lethal influenza infection Influenza virus infection causes severe lung pathology, leading to respiratory distress and mortality [36] . To examine lung pathology in WT and NKC KD mice, lungs were collected 7 days p.
i. with 600 PFU of FM-MA viruses. Microscopic examination of H&E stained lung sections showed more severe alveolar damage, leukocyte infiltration, and pulmonary edema in WT mice compared to NKC KD mice (Fig 3A-3D) . Similar results were obtained with 1050 PFU (S2B Fig) . From these data, we attribute the increased mortality in WT mice over NKC KD to V expression was detected on lung NK cells of uninfected WT and NKC KD mice using anti-NKp46, anti-TCRβ, and a combination of 4D11, 4E5 and 14B11 mAb. NKG2D, NKp46, CD11b, and CD27 expression was detected on lung NK cells, defined using anti-CD49b (DX5) and anti-TCRβ. The gray line represents staining with an isotype antibody. This experiment was performed three times with similar results. (E) Groups of age and sex-matched WT, Ly49Q KO , and NKC KD mice were infected with FM-MA virus (1050 PFU) and monitored for 2 weeks. Data are pooled from two independent experiments (n = 19 in each group). (F) Groups of age and sex-matched NKC KD mice with or without NK depletion by anti-asialoGM1 were infected and monitored as above. A group of uninfected, NK-depleted mice was included as a control (n = 10 in each group). The percentage of surviving mice is shown. *p < 0.05, **p < 0.01 and ***p < 0.001. Statistical analysis was performed with the log rank test. more severe influenza-induced-and possibly immune-mediated-lung pathology. Next, we asked whether NKC KD mice can eliminate influenza virus-infected cells more efficiently than WT mice, possibly leading to less viral burden and inflammation. To avoid survivor bias and ensure that the observed effect is due to innate immune responses, lungs were collected from infected WT and NKC KD mice 5 days p.i., and viral titers were determined. Interestingly, viral titer in NKC KD mice was significantly lower than in WT mice on day 5 p.i. (Fig 3E) , while viral loads were equivalent between the two on days 3 and 8 p.i. (S7A Fig). This result indicates that NKC KD mice are better than WT mice at controlling lung viral loads early during infection.
Better control of the virus may lead to lower levels of inflammation and decreased lung injury following influenza virus infection in NKC KD mice.
Ly49 deficiency results in significantly decreased levels of proinflammatory cytokine and chemokine levels in the lungs of NKC KD mice after influenza virus infection
In addition to injury resulting from influenza virus replication, pro-inflammatory cytokines and chemokines have been suggested to play a pathogenic role in humans and animals infected with influenza virus [37, 38] . We have demonstrated previously that, similar to WT mice, NK cells from NKC KD mice produce normal levels of cytokines upon stimulation with tumor cell lines, anti-NKp46 mAb, and after murine CMV (MCMV) infection [20] . To address the role of pro-inflammatory cytokines and chemokines in the pathogenesis of influenza viruses, we determined the cytokine and chemokine profile in the lungs of influenza-infected WT and NKC KD mice by bead array flow cytometry, 5 days p.i. The majority of cytokines had similar baseline levels in WT and NKC KD mice (S8 Fig). However, the most striking differences occurred in the levels of TNF-α, IFN-γ, IL-17, MCP-1, MCP-3, and MIP-1β, which were elevated significantly in lung homogenates of WT mice compared to the NKC KD mice (Fig 4A-4F ). These remarkable changes in pro-inflammatory cytokines and chemokines in the lungs of influenza virus-infected WT mice suggest their involvement in lung pathology. Furthermore, while we noticed a trend toward elevated IFN-γ and TNF-α in the WT lung NK cells themselves (Fig 4G and 4H) , it is likely that other immune cells in the microenvironment are contributing to the cytokine profile we observe in the bulk lung extracts.
Early NK but not influenza virus-specific T cell increase in the lungs of influenza virus-infected mice
To demonstrate that the observed significant differences in cytokine levels and influenza virus load in the lungs of WT mice at day 5 p.i. is dependent on an NK cell response, we quantified the immune cell subsets responding to viral infection. We examined the NK cell and the virusspecific CD8 + and CD4 + T cell responses in the lungs of influenza virus−infected WT and NKC KD mice 5 and 7 days p.i. Assessment of the percentage and absolute number of these lymphocyte subpopulations after influenza virus infection showed that a protective response to the infection within the first 5 days directly correlated with NK cell expansion (Fig 5A-5F ), and not that of virus-specific CD4 + or CD8 + T cells. Substantial CD4 + and CD8 + T lymphocyte counts were only observed 7 days post-influenza virus infection ( Fig 5A-5D) ; however, flow cytometry detected an expansion of the NK cell population in all mice 5 days p.i. (Fig 5E-5F) . Notably, the percentage and the number of NK cells from both WT and NKC KD mice show that there is no statistically significant difference between both groups 5 days p.i. However, the number of NK cells was significantly higher in WT mice ( ÃÃ p = 0.0031) compared to NKC KD mice (Fig 5F) 7 days p.i., most likely as a result of the reduction in virus load along with cytokine levels in the lungs of NKC KD mice at day 5. These data strongly suggest that activation Cytokine and chemokine levels in the lungs of influenza virus-infected mice. Groups of age and sex-matched WT and NKC KD mice were infected intranasally with 600 PFU of FM-MA virus. Lungs were collected on day 5 p.i., and lung tissue homogenates were prepared. The levels of (A) IFN-γ, (B) TNF-α, (C) IL-17, (D) MCP-1, (E) MCP-3, and (F) MIP-1β in the lung tissue homogenates were measured by flow cytometry using FlowCytomix Multiplex kits. Data are pooled from three independent experiments. (G, H) NK cells were isolated from infected lungs, stained, and analyzed by flow cytometry as above. Cells were stained with a fixable viability dye, anti-NKp46, anti-TCRβ, and anti-IFN-γ (G) or anti-TNF-α (H). Horizontal bars represent mean values. Each symbol represents data from a single mouse. *p < 0.05, **p < 0.01 and ***p < 0.001. Statistical analysis was performed using Student's t-test. and increase in NK cell numbers within the first 5 days post-influenza virus infection enhances the antiviral response mediated by NK cells, and as a result, plays a substantial role in the initial control of influenza virus, especially by NKC KD mice.
Direct contribution of Ly49 inhibitory receptors in the pathogenesis of influenza virus
To test the direct contribution of self-MHC-I-specific Ly49 inhibitory receptors in the pathogenesis of influenza virus, we introduced the inhibitory self-MHC-I-specific Ly49I transgene into NKC KD mice through breeding as previously described [20] . 
NK cell-mediated early defense against influenza virus infection requires both IFN-γ and perforin
Our data strongly suggest that an early increase in NK cell numbers in the lungs during influenza virus infection enhances the antiviral response and the initial control of influenza virus, especially in NKC KD mice. NK cells can directly limit virus replication by killing infected cells via the release of cytotoxic granules containing perforin and granzymes, or indirectly by producing IFN-γ, which plays a role in macrophage activation and in inhibiting viral replication. We wanted to address whether perforin or IFN-γ protects NKC KD mice against influenza virus infection. To determine whether the absence of perforin can be fatal for NKC KD mice, we crossed NKC KD mice to perforin-deficient mice (Prf -/-) on the C57BL/6 background to obtain NKC KD -Prf -/-mice. We inoculated NKC KD and NKC KD -Prf -/-mice with influenza virus intranasally. Interestingly, in contrast to NKC KD mice, all NKC KD -Prf -/-mice succumbed to the influenza infection (Fig 7A) . Similarly, to address the role of IFN-γ, two groups of NKC KD mice were inoculated with influenza virus intranasally. We neutralized IFN-γ in one group of influenza-infected mice using anti-IFN-γ mAb injections two days prior to and at the day of influenza infection, and every two days until day 10 p.i. As a control, a group of uninfected NKC KD mice were treated with anti-IFN-γ mAb as well. Almost 90% of influenza virusinfected NKC KD mice that were treated with anti-IFN-γ mAb died from the infection (Fig 7B) .
Both the NKC KD -Prf -/-and anti-IFN-γ mAb-treated NKC KD mice had higher lung viral titers compared to the NKC KD control group on day 5 and 7, prior to the engagement of an adaptive immune response (Fig 7C) . These data show that protective NK cell-mediated antiviral defenses in NKC KD mice during influenza virus infection require both IFN-γ and perforin.
Discussion
In the current study, we demonstrate for the first time that disrupting the interaction between MHC-I and Ly49 inhibitory receptors on NK cells protects mice from lethal influenza virus infection. Here, we found that the proportion of lung epithelial cells that express MHC-I increased dramatically following influenza virus infection, in an IFN-I independent manner. We also provide evidence for the relevance of this upregulation in the severity of influenza virus infection, in which upregulation of MHC-I on lung epithelial cells in the presence of Ly49:MHC-I interactions allows influenza virus to escape recognition by NK cells, facilitating viral replication and mouse mortality. This demonstrates the direct contribution of Ly49: MHC-I interactions in the severity of influenza virus infection. The human analogues of the mouse Ly49 receptors are the KIRs. Previous studies have reported that patients with either mild or severe pandemic influenza A H1N1/2009 virus infections had significantly higher levels of inhibitory KIR2DL5 gene expression in comparison to healthy individuals [40] . The presence or absence of interactions between NK cells expressing the KIR2DL5 inhibitory receptor and targets expressing its MHC-I ligand could be responsible for the severity of influenza virus infection in human patients. Moreover, another group observed that inhibitory KIR2DL2 and KIR2DL3 allotypes and their cognate ligands, HLA-C1 and HLA-C2, respectively, are significantly enriched in H1N1/2009 intensive-care unit patients in comparison to healthy individuals [41] . Taken together, these reports suggest that potential associations of specific inhibitory KIRs and their MHC-I ligands during severe influenza A virus infections may result in decreased NK function and increased virus pathogenicity. In vitro studies have shown that impairment of human NK cell activity is directly mediated by the accumulation of MHC-I molecules on the surface of influenza virus-infected cells, which in turn increases binding of the NK cell inhibitory receptor KIR2DL1 to the infected cells and inhibits human NK cell-mediated cytotoxicity against them in vitro [11, 12] . MHC-I upregulation by influenza virus may act as a mechanism to evade NK cell recognition by inhibiting NK cell functions via inhibitory Ly49 engagement. Disrupting this interaction between MHC-I and inhibitory NK cell receptors in humans may interfere with this and reduce the severity of an infection. mouse i.p. two days prior to influenza virus infection, on the day of infection (600 PFU), and every two days after until day 10 p.i. Data are pooled from two independent experiments (n = 10 in each group). (C) Groups of age and sex-matched WT (B6) mice were treated or not with 200 μg of 5E6 F(ab') 2 mAbs per mouse i.p. two days prior to influenza virus infection (600 PFU), on the day of infection, and every two days post-influenza virus infection until day 10 p.i. Data are pooled from two independent experiments (n = 16 in each group). *p < 0.05, **p < 0.01 and ***p < 0.001. Statistical analysis was performed with the log rank test.
doi:10.1371/journal.ppat.1005446.g006 , we show that unlicensed NK cells are chiefly responsible for protection from influenza, which may also be true with other viral infections. This could be explained by the lack of inhibitory Ly49 receptors which, if engaged by their MHC-I ligands on the virusinfected cells, could otherwise result in NK cell inhibition (Fig 7D) . This hypothesis is supported by our F(ab') 2 fragment-mediated Ly49C/I blockade, which was found to be protective in WT mice against influenza virus infection, possibly by disrupting the Ly49C inflammatory cytokines known to cause severe lung damage and a high rate of mortality during influenza virus infection [38, 42] . Survival of MHC-I-deficient mice infected with influenza virus was previously attributed to the lack of cytotoxic CD8 + T cells and hence reduced pulmonary damage in these mice [43] . Our data, on the other hand, show a dominant role for NK cells in the protection of these mice against influenza virus infection, since depletion of NK cells makes them susceptible. Consistent with our observations is the reported reduced frequency of NK cells in patients with severe H1N1/2009 infections; CD8 + effector T cells were detected at normal levels in these patients [44] . Our study identifies the mechanisms by which influenza virus escapes recognition by NK cells. Disrupting this interaction between MHC-I and inhibitory NK cell receptors in vivo interferes with this evasion mechanism and, thus, alters the severity of the infection. Additionally, we have demonstrated a previously unidentified role for unlicensed NK cells of the innate immune system. These observations open up a new field of investigation related to NK cell education and encourage more precise elucidation of the nature of each of these functional NK subsets.
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